Skip to main content
Journal of the Chinese Medical Association : JCMA logoLink to Journal of the Chinese Medical Association : JCMA
. 2021 Jul 16;84(9):821–826. doi: 10.1097/JCMA.0000000000000587

The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19

Yu-Ju Lai a, Huan-Shuo Chang b, Yi-Ping Yang c, Tzu-Wei Lin c, Wei-Yi Lai c, Yi-Ying Lin c, Cheng-Chang Chang a,*
PMCID: PMC12966109  PMID: 34282078

Abstract

Different dietary nutrients have distinct effects, including enhancing immune response activity and supporting mucous membrane integrity. These effects are critical in fighting against pathogenic agents, which cover coronavirus disease 2019 (COVID-19), the coronavirus disease that shuts down globally. Recent researches have shown that micronutrient deficiency is commonly associated with compromised immune responses, respiratory tract infections, or even susceptibility to COVID-19. The relationship between Vit A and infection is its role in mucosal epithelium integrity (skin and mucous membrane), the supplementation could be an option for assisted-treating the SARS-CoV-2 virus and a possible prevention of lung infection. Vit C/ascorbic acid stimulates oxygen radical scavenging activity of the skin and enhances epithelial barrier function. Ascorbic acid alone or with other natural compounds (baicalin and theaflavin) may inhibit the expression of angiotensin-converting enzyme II in human small alveolar epithelial cells and limited the entry of SARS-CoV-2. Vitamin D receptors can be expressed by immune cells, and different immune cells (macrophages, monocytes, dendritic cells, T cells, and B cells) can convert Vit D into its active form 1,25-(OH)2 D. Oral vitamin D intake can be a readily way to restrict the viral infection through downregulation of ACE2 receptor and to attenuate the disease severity by decreasing the frequency of cytokine storm and pulmonary pro-inflammatory response. Vit E supports T-cell mediated functions, optimization of Th1 response, and suppression of Th2 response. Vitamin E supplementation can lower the production of superoxides and may favors the antioxidants and benefit the progress of COVID-19 treatment. Zinc plays an essential role in both innate and adaptive immune systems and cytokine production, and Zinc-dependent viral enzymes to initiate the infectious process have proved the Zinc levels are directly associated with symptoms relieved of COVID-19. Iron is an essential component of enzymes involved in the activation of immune cells, lower iron levels predispose to severe symptoms of SARS-CoV-2, and monitoring the status can predict the disease severity and mortality. Selenium participates in the adaptive immune response by supporting antibody production and development. Deficiency can reduce antibody concentration, decreased cytotoxicity of NK cells, compromised cellular immunity, and an attenuated response to vaccination. The COVID-19 vaccines including three broad categories, protein-based vaccines, gene-based vaccines (mRNA vaccines and DNA vaccines), combination of gene and protein-based vaccines. Micronutrients are involved in immunity from the virus entering the human to innate immune response and adaptive immune response. Micronutrients are indispensable in immune response of vaccination.

Keywords: COVID-19, Immunomodulation, Micronutrient, Vaccine

1. INTRODUCTION

Coronavirus disease 2019 (COVID-19), burst out from Wuhan city, China, rapidly becomes a global pandemic after the first confirmed case was identified. As of May 20, 2021, there have been more than 160 million confirmed cases and more than 3.4 million deaths based on WHO’s statistics. The pathogenic agent for the disease is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The primary mode for it to transmit is through air droplets in close contact that causes respiratory tract infection (RTI) with pulmonary dysfunction. Its clinical features may include asthenia, pyrexia, dyspnea, septic shock, coagulation dysfunction, and acute respiratory distress syndrome (ARDS) in clinically ill patients.1 Studies have shown that malnutrition is common in certain groups of people, and among these people, micronutrient deficiency makes them susceptible to infectious diseases.2 Therefore, to keep micronutrient balance is essential to alleviate morbidity of being infected by pathogens.

2. VITAMIN A

Vitamin A (Vit A) significantly affects the regulation of the innate (via natural killer cells, macrophages, and neutrophils) and the cell-mediated immunity (via the growth and differentiation of B cells). It also plays a role in the inflammatory response when being active in cytokine signaling and humoral antibody immunity.3 For instance, Vit A and some other retinoids can increase the efficacy of type 1 interferons (IFN-1), a significant antiviral cytokine released by the innate immune system.4 During the early viral infection (viruses that are utilized to test against SARS-CoV-2), the innate immune system responds to it by releasing IFN-1; however, the coronavirus that resembles SARS-CoV-2 can suppress IFN-1 activity.5 Retinoids, which are family molecules relevant to Vit A that share immune-modulating properties, can potentially enhance the actions of IFN-1 and its most active form is found to be retinoic acid.6 Therefore, Vit A and its related substance such as retinoid can be used to test the antiviral drugs in preclinical trials for COVID-19 treatment.5

The relationship between Vit A and infection is its role in mucosal epithelium integrity (skin and mucous membrane). Since the Vit A maintains immune function, vision, eye health, and all the growth demanding activities in bodies, the deficiency results in increased susceptibility to infection through the eyes, respiratory, and gastrointestinal tract.79 There are trials of animal, and a few human clinical trials are ongoing (IRCT20180520039738N2, IRCT20170117032004N3), yet still no direct evidence suggesting Vit A supplementation as a recommended treatment for clinically confirmed cases of COVID-1910,11; however, the supplementation could be an option for assisted-treating the SARS-CoV-2 virus and a possible prevention of lung infection.12

3. VITAMIN C

Vitamin C (Vit C) is an efficient antioxidant that not only donates electrons readily but scavenges damaging reactive oxygen species; the former strengthens the function and activity of immune cells (leukocyte function and white blood cell migration through monocyte and neutrophil mobilization),13 and the latter prevents our cells and tissues from being damaged by oxidative agents. When the body is being infected, Vit C levels may reduce, and a person requires more of it to balance out the situation.14 Vit C stimulates oxygen radical scavenging activity of the skin and enhances epithelial barrier function.13 Deficiencies impair immunity and lead to higher susceptibility to infection, which further exacerbate disease severity and increases the risk of contracting pneumonia.15 The function of the impaired epithelial barrier of animals’ lung can be reconstructed by Vit C administration.16 Supplementing Vit C can effectively prevent and treat RTI, with being proved to reduce the frequency and span of upper RTI and severity of pneumonia found in hospitalized elderly.17 However, a recent study points out that high-dose supplementation has limited effects on critically ill patients with ARDS.18 In adaptive immunity, Vit C can enhance the differentiation and proliferation of B and T cells.19

Regarding the COVID-19 treatment, an oral low dose (1-2 g/d) can be helpful prophylactically, and in the severe cases, a high-dose (even very high) supplementation may be beneficial.20,21 Besides, ascorbic acid alone or with other natural compounds (baicalin and theaflavin) may inhibit the expression of angiotensin-converting enzyme II in human small alveolar epithelial cells and limited the entry of SARS-CoV-2.22 Vit C may play a protective role in the SARS-CoV-2 pandemic.

4. VITAMIN D

Vitamin D (Vit D) is fat-soluble and is essential in calcium homeostasis. Our skin synthesizes Vit D endogenously as it is exposed to ultraviolet-B radiations from sunlight, which 1,25-dihydroxy vitamin D [1,25-(OH)2 D] is its active form.23 It is also widely associated with suppressing the cytokine storm and strengthening the immune responses, whether innate or adaptive, which protect us against viral infection.24 A study shows that both pro-inflammatory and anti-inflammatory cytokines are generated by the innate immune system of people suffering from COVID-19.25 Vit D receptors (VDRs) can be expressed by immune cells, and different immune cells (macrophages, monocytes, dendritic cells, T cells, and B cells) can convert Vit D into its active form 1,25-(OH)2 D; this mechanism allows local regulation of the active Vit D to work at the site where inflammation happens.26 High levels of VDRs, in particular, exist in lung epithelial cells, of which the deletion may reduce pulmonary barrier integrity and increase lung permeability.27 Activating Vit D in the lung then may attenuate inflammatory cytokines and stimulate these antimicrobials in pulmonary barrier and lung permeability with response to viral infection.

Supplementing Vit D has been proved to effectively combat conditions such as RTI, tuberculosis, asthma, and chronic obstructive pulmonary disease.2831 More importantly, a meta-analysis of randomized controlled trials indicates that supplementing Vit D reduces the frequency of RTIs, by which the dosing frequency and the baseline status are found to be independent modifiers of risk.29 Supplementation effects are most vital in patients with baseline status (<25 nmol/L) and in groups that take it daily. A study of COVID-19 cases has postulated that oral Vit D intake can be a readily way to restrict the viral infection through downregulation of ACE2 receptor and to attenuate the disease severity by decreasing the frequency of cytokine storm and pulmonary pro-inflammatory response.32 Therefore, the use of Vit D may become an “at-hand tool” in the fight against COVID-19 (Fig. 1).

Fig. 1.

Fig. 1

The role of micronutrient and COVID-19 infection. All the micronutrients listed (Vit A, C, D, E, zinc, iron, selenium) can strengthen immune responses by enhancing immune cells activity. Vit A, C, and D can improve epithelial barrier integrity. Vit C, E, zinc, and selenium protect epithelium by displaying antioxidant properties. Enhanced epithelial barrier integrity, especially on ciliated cells, can be beneficial to prevent viral infection. COVID-19= coronavirus disease 2019.

5. VITAMIN E

Vitamin E (Vit E) is a fat-soluble antioxidant that prevents cell membranes’ integrity from being damaged by free radicals. Animal trials evidence demonstrates that Vit E deficiency compromises both cell-mediated and humoral immune function.33,34 It supports T-cell mediated functions, optimization of Th1 response, and suppression of Th2 response.35 Supplementation above the recommended levels has been displayed to strengthen immunity and increase resistance against several pathogens.36,37 Compared to animals, only a limited number of human trials have shown the effects of Vit E on resistance against infectious diseases (Table 1). These human trials’ main focus aims at the elderly, whom the groups commonly contract respiratory diseases.38

Table 1.

Vaccines of COVID-19

Vaccine Manufacturer Platform Dosage Clinical stage Storage Overall efficacy Approvals
mRNA-1273 Moderna (US) mRNA 2 3 −20°C 92.1% after 1 dose, 94.1% after 2 doses Approved in Switzerland, EUA in the United States, EU, Canada, and the United Kingdom
BNT162b2 Pfizer-BioNTech (United States) mRNA 2 3 −70°C 52% after 1 dose, 94.6% after 2 doses Approved in several countries, EUA in United States, EU, Canada, and the United Kingdom
ChAdOx1 AstraZeneca/Oxford (United Kingdom) Viral vector 2 3 2 to 8°C 64.1% after 1 dose, 70.4% after 2 doses Approved in Brazil, EUA in WHO/Covax, United Kingdom, India, and Mexico
Ad26.CoV2.S Janssen/Johnson & Johnson (United States) Viral vector 1 3 2 to 8°C 72% in the United States, 66% in Latin America, 57% in South Africa EUA in United States, EU, and Canada
Gam-COVID-Vac Gamaleya National Research Center for Epidemiology and Microbiology (Russia) Viral vector 2 3 −20°C or 2 to 8°C 87.6% after 1 dose, 91.1% after 2 doses EUA in Russia, Belarus, Argentina, Serbia, United Arab Emirates, Algeria, Palestine, and Egypt
NVX-CoV2373 Novavax, Inc (United States) Protein subunit 2 3 2 to 8°C 89.3% in the United Kingdom after 2 doses, 60% in South Africa
BBIBP-CorV Sinopharm 1/2 (China) Inactivated virus 2 3 2 to 8°C Unpublished reports of 79% and 86% Approved in China, United Arab Emirates, and Bahrain. EUA in WHO, Serbia, Peru, and Zimbabwe
CoronaVac Sinovac Biotech (China) Inactivated virus 2 3 2 to 8°C Unpublished reports after 2 doses, 50.38% for mild, 78% for mild to severe in Brazil, 65% in Indonesia, 91.25% in Turkey Approved in China, EUA in WHO, Brazil, Columbia, Bolivia, and other countries
UB-612 COVAXX(United States)/United Biomedical Inc, Asia (Taiwan) Protein subunit 2 2 2 to 8°C
MVC-COV1901 Medigen Vaccine Biologics Corporation (Taiwan)/NIAID/Dynavax (United States) Protein subunit 2 2 2 to 8°C

COVID-19=coronavirus disease 2019.

Studies have shown that oxidative stress is one of the main driving pathological mechanisms which support the influence of ARDS corresponding to COVID-19 infection.6 Vit E supplementation can lower the production of superoxides and may then tilt the balance back, which favors the antioxidants and benefit the progress of COVID-19 treatment.6

6. ZINC

The body contains little Zinc, and thus inadequate intakes may result in a deficiency that can compromise immunity.39 More specifically, deficiency is associated with immune dysfunction and increased susceptibility to infectious diseases.40 Zinc plays an essential role in both innate and adaptive immune systems and cytokine production. It also displays antioxidant property that protects the body against reactive oxidative species; therefore, Zinc’s proper status in the body acts as an anti-inflammatory compound that optimizes immune response and further reduces the infection rate.41

The recent studies of Zinc-dependent viral enzymes to initiate the infectious process have proved the Zinc levels are directly associated with symptoms relieved of COVID-19.42 Results found from four hospitalized patients diagnosed with COVID-19 have shown that their symptoms were alleviated after being treated with high-dose of zinc salts (15-23 mg/d) orally, indicating that high-dose zinc treatment may become an option for clinical recovery.43

7. IRON

Iron takes part in several immune processes, and is also an essential component of enzymes involved in the activation of immune cells.44 Its structure makes it a mediator of oxidative stress situations and a producer of highly toxic hydroxyl radicals against infectious agents.44 Deficiency is linked to the attenuated efficacy of immune cells (NK cells and lymphocytes) and reduced cytokine production.44 Oppositely, excessiveness can produce cellular toxicity, the titer should be monitor closely.

Concerning COVID-19, lower iron levels predispose to severe symptoms of SARS-CoV-2, monitoring the status can predict the disease severity and mortality.45

8. SELENIUM

Selenoprotein, which acts as cellular antioxidants, is involved in immune responses and is influenced by selenium status.46 It mainly play a role in several components of the innate immune system by differentiation, proliferation, and normal functioning of these components.47 Moreover, selenium also participates in the adaptive immune response by supporting antibody production and development. Therefore, deficiency can reduce antibody concentration, decreased cytotoxicity of NK cells, compromised cellular immunity, and an attenuated response to vaccination. Supplementation of selenium can recover and also enhance the immune response to the virus.48

9. IMMUNITY OF VACCINATION

Vaccination seems to be the most efficient way to control the pandemic currently. According to World Health Organization, more than 200 vaccine candidates are in development and more than 60 of them are in clinical trials. Till February 18, 2021, at least seven different vaccines are available worldwide. COVID-19 vaccines have three broad categories, first is protein-based vaccines, such as inactivated virus vaccines and virus-like particles; second is gene-based vaccines, such as viral vector vaccines, mRNA vaccines, and DNA vaccines; third is combination of gene and protein-based vaccines, such as live-attenuated virus vaccines.49 According to centers for disease control and prevention in the United States, three vaccines are recommended in the United States: Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen. The former two are mRNA vaccines, the later is a viral vector vaccine. Pfizer-BioNTech access an mRNA-lipid nanoparticle vaccine that encodes the S protein receptor-binding domain (BNT 162b1) in humans; Moderna produced mRNA-1273 that encodes SARS-CoV-2 S protein that also encapsulated in lipid nanoparticle.50,51 The lipid nanoparticle entered the human cell and mRNA is translated to antigenic protein in cytoplasm. The antigenic protein presented to cytotoxic T lymphocytes (CTLs) via major histocompatibility complex (MHC) I pathway and presented to helper T cells and B cells via MHC II pathway.52 B cells can make antibodies to neutralize the virus and CTLs can amplify the process of making antibodies. Another platform, viral vector vaccine, Ad26.COV2.S is a replication-deficient adenovirus type 26 particle that contains the S protein DNA of SARS-CoV-2 made by Johnson & Johnson/Janssen. It enters the human cell by a non-infectious adenovirus and transport DNA into the cell that will transduction to mRNA and translation to S protein. The S protein can initiate later immune response like the mRNA vaccines53 (Fig. 2).

Fig. 2.

Fig. 2

Immune response of COVID-19 vaccination. The figure depicts the immune response of mRNA vaccine and viral vector vaccine. After entering the human body, both of them can make S protein that present to our immune cells and have cytotoxic T cell maturation, antibody made by B cell. COVID-19=coronavirus disease 2019.

Micronutrients are involved in immunity from the virus entering the human to innate immune response and adaptive immune response. Vit A, C, D, E, Fe, and Zn can keep epithelial integrity and make respiratory tract barriers. Vit C, E, Fe, Zn, and Se are efficient antioxidants. In innate immunity, Vit A, E, Zn, and Se regulate natural killer function. Vit C, D can support the immune cells activities, movement, and functions. In adaptive immunity, Vit A, E are mediated with Th1 and Th2 development. Vit E makes memory T cell increased. Vit A, C, Se help the production of antibody by B cell.9,19,35,5456 Micronutrients are indispensable in immune response of vaccination.

In conclusion, at least as of recent studies, little evidence indicates a strong correlation between certain micronutrient supplementation and COVID-19 treatment. Prophylactic supplementation, however, has been proved in several trials to enhance our immune responses and to reduce the contraction of many infectious diseases. Depending on the properties of distinct micronutrient supplementation, effects vary and some of them can backfire on body if having excessive intake. Influences of deficiency are harmful and also differ because certain vitamins or metal salts support certain functions of body. Micronutrients do play important roles in physical barrier to innate and adaptive immunity.

ACKNOWLEDGMENTS

This research was supported in part by the following grant from the Tri-Service General Hospital (TSGH-D-110135) and the The-Tzer Study Group for Human Medical Research Foundation. We would like to thank Hui-Yin Su for figure editing.

Footnotes

Author Contributions: Yu-Ju Lai and Huan-Shuo Chang contributed equally to this work.

Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.

REFERENCES

  • 1.Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;66:549–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.McAuliffe S, Ray S, Fallon E, Bradfield J, Eden T, Kohlmeier M. Dietary micronutrients in the wake of COVID-19: an appraisal of evidence with a focus on high-risk groups and preventative healthcare. BMJ Nutr Prev Health. 2020;3:93–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alpert PT. The role of vitamins and minerals on the immune system. Home Health Care Manag Pract. 2017;29:199–202. [Google Scholar]
  • 4.Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. Plos Med. 2006;3:e343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Trasino SE. A role for retinoids in the treatment of COVID-19? Clin Exp Pharmacol Physiol. 2020;47:1765–7. [DOI] [PubMed] [Google Scholar]
  • 6.Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, et al. Could vitamins help in the fight against COVID-19? Nutrients. 2020;12:E2550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Semba RD. The role of vitamin A and related retinoids in immune function. Nutr Rev. 1998;56(1 Pt 2):S38–48. [DOI] [PubMed] [Google Scholar]
  • 8.Rice AL, West KP, Jr, Black RE. Vitamin A deficiency. Comparative quantification of health risks: global and regional burden of disease attributes to selected major risk factors Geneva. WHO. 2004:211–56. Available at https://www.academia.edu/37037440/Comparative_Quantification_of_Health_Risks_Global_and_Regional_Burden_of_Disease_Attributable_to_Selected_Major_Risk_Factors. [Google Scholar]
  • 9.Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of vitamin A in the immune system. J Clin Med. 2018;7:E258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jee J, Hoet AE, Azevedo MP, Vlasova AN, Loerch SC, Pickworth CL, et al. Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. Am J Vet Res. 2013;74:1353–62. [DOI] [PubMed] [Google Scholar]
  • 11.West CE, Sijtsma SR, Kouwenhoven B, Rombout JH, van der Zijpp AJ. Epithelia-damaging virus infections affect vitamin A status in chickens. J Nutr. 1992;122:333–9. [DOI] [PubMed] [Google Scholar]
  • 12.Michele CA, Angel B, Valeria L, Teresa M, Giuseppe C, Giovanni M, et al. Vitamin supplements in the era of SARS-CoV2 pandemic. GSCBPS. 2020;11:7–19. [Google Scholar]
  • 13.Bakaev VV, Duntau AP. Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia. Int J Tuberc Lung Dis. 2004;8:263–6. [PubMed] [Google Scholar]
  • 14.Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21:300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hemilä H. Vitamin C and infections. Nutrients. 2017;9:339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Wegelin JA, Brophy D, et al. Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol. 2012;303:L20–32. [DOI] [PubMed] [Google Scholar]
  • 17.Hunt C, Chakravorty NK, Annan G. The clinical and biochemical effects of vitamin C supplementation in short-stay hospitalized geriatric patients. Int J Vitam Nutr Res. 1984;54:65–74. [PubMed] [Google Scholar]
  • 18.Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322:1261–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9:E1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition. 2020;79-80:110948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hoang BX, Shaw G, Fang W, Han B. Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection. J Glob Antimicrob Resist. 2020;23:256–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ivanov V, Goc A, Ivanova S, Niedzwiecki A, Rath M. Inhibition of ACE2 expression by ascorbic acid alone and its combinations with other natural compounds. Infect Dis (Auckl). 2021;14:1178633721994605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, et al. Rationale and plan for Vitamin D food fortification: a review and guidance paper. Front Endocrinol (Lausanne). 2018;9:373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Khare D, Godbole NM, Pawar SD, Mohan V, Pandey G, Gupta S, et al. Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur J Nutr. 2013;52:1405–15. [DOI] [PubMed] [Google Scholar]
  • 25.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2016;7:697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chen H, Lu R, Zhang YG, Sun J. Vitamin D receptor deletion leads to the destruction of tight and adherens junctions in lungs. Tissue Barriers. 2018;6:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2015; 3:120–30. [DOI] [PubMed] [Google Scholar]
  • 29.Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011;7:337–45. [DOI] [PubMed] [Google Scholar]
  • 31.Jolliffe DA, Greenberg L, Hooper RL, Griffiths CJ, Camargo CA, Jr, Kerley CP, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med. 2017;5:881–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Arboleda J, Urcuqui-Inchima S. Vitamin D supplementation: a potential approach for COVID-19 therapeutics? Front Immunol. 2020; 11:1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gebremichael A, Levy EM, Corwin LM. Adherent cell requirement for the effect of vitamin E on in vitro antibody synthesis. J Nutr. 1984;114:1297–305. [DOI] [PubMed] [Google Scholar]
  • 34.Kowdley KV, Mason JB, Meydani SN, Cornwall S, Grand RJ. Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption. Gastroenterology. 1992;102:2139–42. [DOI] [PubMed] [Google Scholar]
  • 35.Gasmi A, Tippairote T, Mujawdiya PK, Peana M, Menzel A, Dadar M, et al. Micronutrients as immunomodulatory tools for COVID-19 management. Clin Immunol. 2020;220:108545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Meydani SN, Barklund MP, Liu S, Meydani M, Miller RA, Cannon JG, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr. 1990;52:557–63. [DOI] [PubMed] [Google Scholar]
  • 37.Han SN, Meydani SN. Vitamin E and infectious diseases in the aged. Proc Nutr Soc. 1999;58:697–705. [DOI] [PubMed] [Google Scholar]
  • 38.Meydani SN, Han SN, Wu D. Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev. 2005;205:269–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003;133(5 Suppl 1):1452S–6S. [DOI] [PubMed] [Google Scholar]
  • 40.Tuerk MJ, Fazel N. Zinc deficiency. Curr Opin Gastroenterol. 2009;25:136–43. [DOI] [PubMed] [Google Scholar]
  • 41.de Almeida Brasiel PG. The key role of zinc in elderly immunity: a possible approach in the COVID-19 crisis. Clin Nutr ESPEN. 2020;38:65–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Doboszewska U, Wlaź P, Nowak G, Młyniec K. Targeting zinc metalloenzymes in coronavirus disease 2019. Br J Pharmacol. 2020;177:4887–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis. 2020;99:307–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Agoro R, Taleb M, Quesniaux VFJ, Mura C. Cell iron status influences macrophage polarization. PLoS One. 2018;13:e0196921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Serum iron level as a potential predictor of coronavirus disease 2019 severity and mortality: a retrospective study. Open Forum Infect Dis. 2020;7:ofaa250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rayman MP. Selenium and human health. Lancet. 2012;379:1256–68. [DOI] [PubMed] [Google Scholar]
  • 47.Galmés S, Serra F, Palou A. Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients. 2020;12:E2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Maggini S, Beveridge S, Sorbara P, Senatore G. Feeding the immune system: the role of micronutrients in restoring resistance to infections. CAB Rev Perspect Agric Vet Sci Nutr Nat Resour. 2008;3:1–21. [Google Scholar]
  • 49.Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. 2021;21:73–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–93. [DOI] [PubMed] [Google Scholar]
  • 51.Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586:567–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Xu S, Yang K, Li R, Zhang L. mRNA vaccine era-mechanisms, drug platform and clinical prospection. Int J Mol Sci. 2020;21:E6582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12:E2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lee GY, Han SN. The role of vitamin E in immunity. Nutrients. 2018;10:E1614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12:E236. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Chinese Medical Association : JCMA are provided here courtesy of Wolters Kluwer Health

RESOURCES